← SynDRA
DAZMEGREL
SynDRA canonical compound SYN0001580 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | TBXAS1 |
|---|
| Mechanism of action | Thromboxane synthase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Thromboxane synthase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CP1A2
- CP2C9
- CP2CJ
- CP3A4
- CP3A7
Drug classes
- Enzyme Inhibitors
- Platelet Aggregation Inhibitors
- Vasodilator Agents
Cross-references
Synonyms
- UK-38,485
- UK-38485
- Dazmegrelum
- UK 38485
- UK 38,485
- 3-(Imidazol-1-ylmethyl)-2-methylindole-1-propionic acid
- DTXCID7026281
- RefChem:919687
- 3-[3-(imidazol-1-ylmethyl)-2-methylindol-1-yl]propanoic acid
- NCGC00160660-01
- Dazmegrelum [Latin]
- CAS-76894-77-4
- Dazmegrel [USAN:INN:BAN]
- UNII-31340R8PVU
- DAZMEGREL [INN]
- Dazmegrel (USAN/INN)
- DAZMEGREL [USAN]
- DAZMEGREL [MART.]
- Oprea1_040141
- CBDivE_000516
- SCHEMBL154037
- orb1697567
- Tox21_111966
- BDBM50000317
- CCG-20521
- STK094650
- AKOS005395464
- Tox21_111966_1
- NCGC00160660-02
- DA-02947
- CS-0024777
- EU-0045204
- NS00120958
- ST50898364
- D03661
- T31213
- AI-981/09942042
- SR-01000082437
Look up DAZMEGREL in the interactive SynDRA portal →